Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma

Clinical trial NCT00807495 · COMPLETED

Trial details

NCT number: NCT00807495
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma Mantle Cell Lymphoma Burkitt's Lymphoma T-cell Lymphoma, Excluding Primary Cutaneous T-cell Lymphoma Transformed Follicular Lymphoma With ≥ 50% Diffuse Large Cell Component

Start date: 2009-02-10
Primary completion: 2011-01-04
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.